CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $13,906 | -26.8% | 145,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $19,000 | -54.8% | 145,000 | -25.6% | 0.00% | 0.0% |
Q2 2022 | $42,000 | -44.7% | 195,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $76,000 | -19.1% | 195,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $94,000 | -13.8% | 195,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $109,000 | -22.7% | 195,000 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $141,000 | -28.4% | 195,000 | -17.0% | 0.00% | -25.0% |
Q1 2021 | $197,000 | +87.6% | 235,000 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $105,000 | +22.1% | 235,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $86,000 | -45.2% | 235,000 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $157,000 | – | 235,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |